Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Preconference

siRNA Therapies

Innovating the landscape: Is MIDD of siRNA unique?

Sunday, November 10, 2024
11:20 AM – 11:45 AM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • NM

    Nitin Mehrotra, Phd

    Head of Pharmacometrics
    Alnylam Pharmaceuticals

    Disclosure(s): Alnylam: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Takeda: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Nitin Mehrotra, Phd: Alnylam: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Takeda: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Back to Top